Approvals/TGA/REPATHA evolocumab (rch) 420 mg /3.5 mL injection solution automated mini-doser AMD

Approved

STANDARD

REPATHA evolocumab (rch) 420 mg /3.5 mL injection solution automated mini-doser AMD

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b8794f6c9fe7e9f7
Product Name: REPATHA evolocumab (rch) 420 mg /3.5 mL injection solution automated mini-doser AMD
Artg Id: 348651
Artg Name: REPATHA evolocumab (rch) 420 mg/3.5 mL injection solution automated mini-doser AMD
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2020-12-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2d412539cc5f1c444776f6dae07f7fa8.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/de0e5ab92a5811514383dae8f0f63a34.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

b8794f6c9fe7e9f7

Type

Standard